| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 174634-08-3 | 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one | C20H19N3O2 |
| 174634-09-4 | 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride;TAS 103 | C20H19N3O2.2(HCl) |
| 174635-69-9 | SB 222200;3-Methyl-2-phenyl-N-((1S)-1-phenylpropyl)quinoline-4-carboxamide | C26H24N2O |
| 174636-32-9 | 3-Hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide;SB 223412; Talnetant | C25H22N2O2 |
| 174648-98-7 | 1,2,3,4-Tetrahydro-6-nitroisoquinoline monohydrochloride | C9H10N2O2.HCl |
| 174649-09-3 | (R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl methanesulfonate | C15H19FN2O6S |
| 174652-94-9 | (E)-2-Benzoyl-3-(dimethylamino)-2-propenenitrile | C12H12N2O |
| 174658-22-1 | 4-Amino-3-mercaptobenzonitrile | C7H6N2S |
| 174669-73-9 | 2-Fluoro-3-pyridylboronic acid;2-Fluoropyridine-3-boronic acid | C5H5BFNO2 |
| 174669-74-0 | 2-Fluoro-3-hydroxypyridine;2-Fluoro-3-pyridinol | C5H4FNO |
| 174671-42-2 | (R)-1-Benzyl-2-methylpiperazine;(2R)-2-Methyl-1-(phenylmethyl)piperazine | C12H18N2 |
| 174671-46-6 | 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole;5-Fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol; AN 2690; Tavaborole | C7H6BFO2 |
| 174672-06-1 | 5-Chloro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole | C7H6BClO2 |
| 174677-83-9 | (S,S)-1,2-Bis[[[2-(diphenylphosphino)phenyl]methyl]amino]cyclohexane | C44H44N2P2 |
| 174689-60-2 | (R,R)-1,1'-Bis(hydroxy(phenyl)methyl)ferrocene | C24H22FeO2 |
| 174699-11-7 | (S)-1,3-Piperidinedicarboxylic acid 3-ethyl 1-(phenylmethyl) ester | C16H21NO4 |
| 174702-59-1 | 4-Bromo-2-methyl-1-indanone | C10H9BrO |
| 174721-08-5 | Ginsenoside Rh4;(3beta,6alpha,12beta,20E)-3,12-Dihydroxydammara-20(22),24-dien-6-yl-beta-D-glucopyranoside | C36H60O8 |
| 174734-34-0 | 5-Methoxy-2-trifluoromethylindole;5-Methoxy-2-(trifluoromethyl)-1H-indole | C10H8F3NO |
| 174735-02-5 | 3,6-Dibromophenanthrene | C14H8Br2 |
| 174758-63-5 | (R,R)-N,N'-Bis[2-(diphenylphosphino)benzyl]cyclohexane-1,2-diamine;N,N'-Bis[o-(diphenylphosphino)benzyl]-1R,2R-diaminocyclohexane | C44H44N2P2 |
| 174775-48-5 | Ethyl 5-amino-1-benzofuran-2-carboxylate;Ethyl 5-aminobenzo[b]furan-2-carboxylate | C11H11NO3 |
| 174794-02-6 | Olanzapine-N-oxide;2-Methyl-4-(4-methyl-4-oxido-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; LY 170238 | C17H20N4OS |
| 174800-02-3 | Fmoc-O-Benzyl-L-4-hydroxyproline;Fmoc-Hyp(Bzl)-OH | C27H25NO5 |
| 174810-09-4 | (1R,2R)-(+)-1,2-Diaminocyclohexane-N,N'-bis(2-diphenylphosphino-1-naphthoyl);(R,R)-DACH-naphthyl Trost ligand | C52H44N2O2P2 |
| 174813-81-1 | Chloro[[(1S,2S)-(+)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido](mesitylene)ruthenium(II);RuCl[(R,R)-Tsdpen(mesitylene) | C30H33ClN2O2RuS |
| 174813-82-2 | Chloro[[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido](mesitylene)ruthenium(II);[N-[(1R,2R)-2-(Amino-kN)-1,2- diphenylethyl]-4-methylbenzenesulfonamidato-kN]chloro [(1,2,3,4,5,6-n)-1,3,5-trimethylbenzene]-ruthenium | C30H33ClN2O2RuS |
| 174824-16-9 | 3,5-Bis(trifluoromethyl)-2-bromoaniline | C8H4BrF6N |
| 174855-53-9 | 4-[2-(Aminomethyl)phenyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C16H25N3O2 |
| 174855-57-3 | 1-Boc-4-(2-formylphenyl)piperazine | C16H22N2O3 |
| 174886-05-6 | 1-Methyl-1-cyclobutanamine hydrochloride;1-Amino-1-methylcyclobutane hydrochloride | C5H11N.HCl |
| 174891-10-2 | (5-Aminopyrazol-3-yl)acetic acid;5-Amino-1H-pyrazol-3-ylacetic acid; 5-Amino-1H-pyrazole-3-acetic acid | C5H7N3O2 |
| 174899-65-1 | 1-Methyl-3-ethylimidazolium trifluoroacetate;1-Ethyl-3-methylimidazolium trifluoroacetate | C6H11N2.C2F3O2 |
| 174899-66-2 | 1-Butyl-3-methylimidazolium trifluoromethansulfonate | C8H15N2.CF3O3S |
| 174899-81-1 | 1-Methyl-3-methylimidazolium bis[(trifluoromethyl)sulfonyl]imide;1,3-Dimethylimidazolium bis[(trifluoromethyl)sulfonyl]imide; 1-Methyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide | C5H9N2.C2F6NO4S2 |
| 174899-82-2 | 1-Ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide | C8H11F6N3O4S2 |
| 174899-83-3 | 1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide;bis(trifluoromethylsulfonyl)azanide;1-butyl-3-methylimidazol-3-ium | C10H15F6N3O4S2 |
| 174899-86-6 | 1-(2-Hydroxyethyl)-3-methylimidazolium bis(trifluoromethanesulfonyl)imide;3-(2-Hydroxyethyl)-1-methylimidazolium bis(trifluoromethanesulfonyl)imide; 3-(2-Hydroxyethyl)-1-methyl-1H-imidazolium salt with 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | C6H11N2O.C2F6NO4S2 |
| 174899-90-2 | 1-Ethyl-2,3-dimethylimidazolium bis(trifluoromethanesulfonyl)imide | C9H13F6N3O4S2 |
| 174899-94-6 | 3-Butyl-1-methylimidazolium trifluoroacetate;Butylmethylimidazolium trifluoroacetate; [BMIM][CF3COO] | C8H15N2.C2F3O2 |
| 174913-09-8 | 2-Bromo-5-chloroanisole | C7H6BrClO |
| 174913-10-1 | 2-Bromo-6-chloroanisole;1-Bromo-3-chloro-2-methoxybenzene | C7H6BrClO |
| 174913-12-3 | 3-Bromo-5-chloroanisole | C7H6BrClO |
| 174913-20-3 | 2-Bromo-1,3-dichloro-5-methoxybenzene | C7H5BrCl2O |
| 174972-79-3 | Parishin B;[2-(Carboxymethyl)-2-hydroxy-1,4-dioxo-1,4-butanediyl]bis(oxymethylene-4,1-phenylene) bis-beta-D-glucopyranoside | C32H40O19 |
| 174972-80-6 | Parishin C;3-Carboxy-3-hydroxy-1,5-dioxo-1,5-pentanediylbis(oxymethylene-4,1-phenylene) bis-beta-D-glucopyranoside | C32H40O19 |
| 175013-18-0 | Pyraclostrobine;Methyl N-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-N-methoxycarbamate | C19H18ClN3O4 |
| 175013-84-0 | Tonabersat;SB-220453; N-[(3S,4S)-6-Acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-3-chloro-4-fluorobenzamide | C20H19ClFNO4 |
| 175018-77-6 | 4-(2-Bromoethyl)-1,2-difluorobenzene;3,4-Difluorophenethyl bromide | C8H7BrF2 |
| 175021-11-1 | 3,3-Dimethoxycyclobutanemethanol;(3,3-Dimethoxycyclobutyl)methanol | C7H14O3 |